Clinical Trials on ER/PR Positive Breast Cancer in Korea, Republic of
Total 836 results
-
Jules Bordet InstituteHoffmann-La Roche; Breast International Group; Institut Curie; International Drug...SuspendedHER2-positive Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast Cancer | Node-negative Breast CancerKorea, Republic of, France, Israel, Belgium, Switzerland, Australia
-
Synta Pharmaceuticals Corp.CompletedBreast Cancer | Triple Negative Breast Cancer | HER-2 Positive Breast Cancer | ER/Progressive Response (PR) + Refractory to Prior Hormonal TreatmentSpain, United States, Argentina, Belgium, Brazil, Korea, Republic of, Peru, United Kingdom
-
Gangnam Severance HospitalSeoul National UniversityRecruitingBreast Cancer | HER2-negative Breast Cancer | Estrogen Receptor Positive Tumor | Premenopausal Breast Cancer | Node-positive Breast CancerKorea, Republic of
-
Korean Cancer Study GroupUnknownPhase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast CancerMetastatic Breast Cancer | HER2-positive Breast CancerKorea, Republic of
-
Seoul National University HospitalActive, not recruitingHormone Receptor-positive Breast Cancer | Premenopausal Breast CancerKorea, Republic of
-
Seoul National University HospitalActive, not recruitingInvasive Breast Cancer | Estrogen Receptor Positive Breast CancerKorea, Republic of
-
National Cancer Center, KoreaActive, not recruitingMetastatic Breast Cancer | HER2-positive Breast CancerKorea, Republic of
-
Yonsei UniversityRecruitingMetastatic Breast Cancer | HER2-positive Breast Cancer | PostmenopausalKorea, Republic of
-
Alteogen, Inc.CompletedHER2-positive Breast CancerKorea, Republic of
-
Samsung Medical CenterRecruitingHER2-positive Breast CancerKorea, Republic of
-
Samsung Medical CenterActive, not recruitingTriple Negative Breast Cancer | HER2-positive Breast CancerKorea, Republic of
-
Samsung Medical CenterUnknownHER2-positive Breast CancerKorea, Republic of
-
AstraZenecaCompletedER+ HER2- Advanced Breast CancerUnited States, United Kingdom, Korea, Republic of
-
Samsung Medical CenterAsan Medical Center; Seoul National University Hospital; Ulsan University Hospital and other collaboratorsUnknownMetastatic Breast Cancer | Estrogen Receptor Positive Tumor | Breast Cancer Nos PremenopausalKorea, Republic of
-
Gencurix, Inc.RecruitingEarly Hormone Receptor-positive Breast CancerKorea, Republic of
-
Samsung Medical CenterActive, not recruitingHER2-positive Breast Cancer | Chemotherapy Effect | Circulating Tumor DNAKorea, Republic of
-
Hoffmann-La RocheRecruitingInoperable, Locally Advanced or Metastatic, ER-positive Breast CancerUnited States, Korea, Republic of, Spain, Australia, Israel
-
Gangnam Severance HospitalSamsung Medical Center; Asan Medical Center; Severance HospitalRecruitingBreast Cancer | Surgery | Recurrent Breast Cancer | Estrogen Receptor Positive Tumor | Stereotactic Body Radiotherapy | Her2-negative TumorKorea, Republic of
-
AstraZenecaActive, not recruitingAdvanced ER-Positive HER2-Negative Breast CancerUnited States, Italy, Spain, Belgium, Poland, Canada, Germany, Korea, Republic of, Russian Federation, France, Israel, Hungary, Portugal, United Kingdom, Georgia, Ukraine
-
Yonsei UniversityRecruitingTriple Negative Breast Cancer | Metastatic Breast Cancer With HER2 PositiveKorea, Republic of
-
Olema Pharmaceuticals, Inc.RecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | HER2 Negative Breast Carcinoma | ER Positive Breast CancerUnited States, Korea, Republic of, Australia, Taiwan, Hong Kong, Malaysia, Thailand, Argentina, Belgium, Portugal, Italy, Czechia, Mexico, Poland, Germany
-
AstraZenecaActive, not recruitingER-Positive HER2-Negative Breast CancerAustria, Belgium, France, Germany, Italy, United Kingdom, United States, Canada, India, Taiwan, Russian Federation, Korea, Republic of, Hungary, Japan, Mexico, Turkey, China, Malaysia, Spain, Czechia, Portugal, Poland, Norway, Bulgaria, Slovaki... and more
-
Seoul National University HospitalCompletedHormone Receptor Positive Malignant Neoplasm of BreastKorea, Republic of
-
Yonsei UniversityRecruiting
-
EnhancedBio USA Inc.ZenopharmRecruitingMetastatic Breast Cancer | Locally Advanced Breast Cancer | HER2-Negative | Estrogen Receptor-PositiveUnited States, Korea, Republic of
-
Samsung Medical CenterCompletedHER2-positive Refractory Advanced CancerKorea, Republic of
-
Samsung Medical CenterRecruitingMetastatic Breast CancerKorea, Republic of
-
Seoul National University HospitalSeoul National University Bundang Hospital; Korean Cancer Study Group (KCSG); Eisai Korea Inc... and other collaboratorsActive, not recruitingMetastatic Breast CancerKorea, Republic of
-
Samsung Medical CenterUnknownBreast Cancer MetastaticKorea, Republic of
-
Samsung Medical CenterUnknownMetastatic Breast CancerKorea, Republic of
-
National Cancer Center, KoreaCompletedGoserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBCMetastatic Breast CancerKorea, Republic of
-
Korean Breast Cancer Study GroupUnknownMetastatic Breast CancerKorea, Republic of
-
AstraZenecaRecruitingER-Positive HER2-Negative Breast CancerUnited States, Israel, Spain, Korea, Republic of, Italy, Poland, Belgium, Norway, Bulgaria, France, Germany, United Kingdom, Japan, Taiwan, Canada, Hungary, Australia, Austria, Portugal, Turkey, Russian Federation, Slovakia, Switzer...
-
Yonsei UniversityNot yet recruitingTNBC - Triple-Negative Breast CancerKorea, Republic of
-
Korea University Guro HospitalRecruitingMetastatic Breast CancerKorea, Republic of
-
Seoul National University HospitalMinistry of Health & Welfare, KoreaRecruitingBreast Cancer InvasiveKorea, Republic of
-
Yonsei UniversityNot yet recruiting
-
Asan Medical CenterEisai Inc.; Dong-A ST Co., Ltd.; Samyang Biopharmaceuticals CorporationCompletedMetastatic Breast CancerKorea, Republic of
-
Samsung Medical CenterCompletedMetastatic Breast CancerKorea, Republic of
-
CelltrionUnknownMetastatic Breast CancerKorea, Republic of
-
Gachon University Gil Medical CenterUnknownMetastatic Breast CancerKorea, Republic of
-
Genentech, Inc.RecruitingEstrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast CancerKorea, Republic of, United States, Spain, Taiwan, United Kingdom, Japan, Germany, Argentina, Turkey, Greece, Italy, Singapore, South Africa
-
National Cancer Center, KoreaActive, not recruitingTriple Negative Breast CancerKorea, Republic of
-
Samsung Medical CenterRecruitingBreast Cancer Stage IIIKorea, Republic of
-
MedicalExcellenceAsan Medical CenterNot yet recruitingYoung Womenwith Breast CancerKorea, Republic of
-
Jeong Eon LeeAsan Medical Center; Seoul National University Hospital; Gangnam Severance Hospital and other collaboratorsActive, not recruiting
-
Asan Medical CenterCompletedBreast CancerKorea, Republic of
-
Chonbuk National UniversityUnknownInterstitial Lung Diseases | Lung Cancer, | ER Stress, | Chronic Airway Disorders,Korea, Republic of
-
Samsung Medical CenterUnknown
-
Samsung Medical CenterUnknownBreast Cancer Stage IVKorea, Republic of